Artwork

Content provided by Christopher Rathbun. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Christopher Rathbun or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Unlocking Trapped Capital in Biotech – Interview with Nick Johnston, founder of Alis Biosciences

39:22
 
Share
 

Manage episode 492482929 series 2427392
Content provided by Christopher Rathbun. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Christopher Rathbun or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Nick Johnston, a former biotech banker and entrepreneur, founded Alis Biosciences to solve one of the biggest challenges that every biotech might face on its road – how to maximize shareholders' value when a public-listed company loses market confidence? Alis creates a safety netfor shareholders by giving the trapped capital back and supporting the company with promising science to get back on track. Since its launch in 2025, Alis has identified over 300 small-cap biotech companies representing nearly $30 billion in underutilized capital, and has already completed successful take-private deals that delivered over 90% of uncommitted cash back to investors - faster and more efficiently than traditional liquidation processes.

In this episode, you will hear about:

  • Why Nick started Alis Biosciences, and how his background in healthcare banking shaped the model.
  • How stagnation in capital markets leaves early-stage biotech companies in limbo and how Alis offers an innovative path forward.
  • Why it still makes sense to invest in new science, and how Alis distinguishes between value traps and scientific opportunity.
  continue reading

35 episodes

Artwork
iconShare
 
Manage episode 492482929 series 2427392
Content provided by Christopher Rathbun. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Christopher Rathbun or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Nick Johnston, a former biotech banker and entrepreneur, founded Alis Biosciences to solve one of the biggest challenges that every biotech might face on its road – how to maximize shareholders' value when a public-listed company loses market confidence? Alis creates a safety netfor shareholders by giving the trapped capital back and supporting the company with promising science to get back on track. Since its launch in 2025, Alis has identified over 300 small-cap biotech companies representing nearly $30 billion in underutilized capital, and has already completed successful take-private deals that delivered over 90% of uncommitted cash back to investors - faster and more efficiently than traditional liquidation processes.

In this episode, you will hear about:

  • Why Nick started Alis Biosciences, and how his background in healthcare banking shaped the model.
  • How stagnation in capital markets leaves early-stage biotech companies in limbo and how Alis offers an innovative path forward.
  • Why it still makes sense to invest in new science, and how Alis distinguishes between value traps and scientific opportunity.
  continue reading

35 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play